Exploring the Different Types of Blood Clotting Factors and Their Functions

 

Blood Clotting Factor
Blood Clotting Factor

Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes.

Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it.

Factor I: Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the clotting process.

Factor IV: Also known as calcium, plays a crucial role in the clotting process by helping to activate the other clotting factors. Factor V, also known as proaccelerin, helps to activate factor X, which in turn activates prothrombin. Factor VI, also known as accelerator globulin, helps to speed up the clotting process.

Factor VII: Also known as stable factor, is activated by tissue factor and helps to activate factor X. Factor VIII, also known as antihemophilic factor, is deficient in people with hemophilia, a genetic disorder that impairs blood clotting. Factor IX, also known as Christmas factor, helps to activate factor X.

Factor X: Also known as Stuart-Prower factor, helps to convert prothrombin into thrombin, which then converts fibrinogen into fibrin. Factor XI, also known as plasma thromboplastin antecedent, helps to activate factor IX. Factor XII, also known as Hageman factor, is activated by contact with a foreign surface, such as a damaged blood vessel.

Factor XIII: Also known as fibrin stabilizing factor, helps to strengthen the blood clot by cross-linking the fibrin strands. Finally, von Willebrand factor, which is produced by platelets, helps to stabilize the clot by binding to both fibrin and platelets.

A number of feedback mechanisms control the blood clotting factors to prevent an excessive or protracted clotting process. Proteins like antithrombin III, which prevents thrombin from working, as well as protein C and protein S, which aid in dissolving blood clots after an injury has healed, are two examples.

Disorders of the blood clotting factors can cause excessive clotting or abnormal bleeding, both of which pose a serious risk to life. A factor VIII or factor IX deficiency caused by the hereditary condition haemophilia causes profuse bleeding. Another hereditary illness, von Willebrand disease, causes a deficit of the von Willebrand factor, which leads in irregular bleeding.

Comments

Post a Comment

Popular posts from this blog

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Image
The material having tiny uniformly sized holes is known as a molecular sieve. Angstroms or nanometers are the units of measurement for molecular sieves (nm). Microporous (2 nm), macroporous (50 nm), and mesoporous molecular sieves are all available (2 nm- 50 nm). Zeolites, crystalline alumino-silicates, are used to make Molecular Sieves. Three-dimensional pore systems were used to describe molecular sieves crystals, and the identical crystals were recognised as a group. Commercially available absorbents are basic Molecular sieves kinds A and X. As absorbents for fluids, molecular sieves are utilised (gas and liquids). Fluids can be separated using molecular sieve absorbents based on their size and polarity. When it comes to hydrocarbons, there are a number of factors to consider. Molecule sieve absorbents may separate liquids based on their molecular size and polarity. Straight molecules fit into pores and are absorbed in the case of hydrocarbon parafines. The branching molecules are
Read more

Biolubricants Market Size, Share, Growth, Opportunities, Global Analysis and Opportunity Assessment 2019 – 2027

Image
                                                                                                   Biolubricants Market Chemical modifications of plant-based oils, such as epoxidation, transesterification, and esterification processes, are used to make bio-lubricants. These lubricants are commonly used to decrease friction between various surfaces. Bio-lubricants are used in heavy machinery such as railroad flanges, chainsaw bars, and two-stroke engines because they are non-toxic, eco-friendly, bio-degradable, and renewable. Aside from that, they are less expensive to use and have various advantages over synthetic and mineral oil-based lubricants. Currently, technical improvements, together with increased research and development (R&D) activities by major partners, are opening up new bio-lubricant application possibilities. Over the forecast period, the worldwide Biolubricants Market is expected to rise due to rising demand for sustainable alternatives to petroleum-based lubrican
Read more

Shared Services Market by Function, By Number of Services and By Region – Global Opportunities & Forecast 2019 - 2027

Image
                                                 Shared Services Market Shared services are a specialised entity that focuses on specific business operations and includes procedures, people, and technologies. It's set up as a single point of contact for servicing and delivery. These functions, which are supported by IT and IT services, cater to the needs of various business divisions inside the company. Shared services can include a wide range of IT procedures and business tasks, as well as originate from a variety of physical locations. The global Shared Services Market is expected to grow in response to the rapidly expanding need for cost-effective treatment modalities and the rethinking of the old pharmaceutical R&D paradigm. Due to a growth in the number of agreements in the Shared Services Industry throughout the public and private sectors, the market is likely to develop quickly. The Global Shared Services Market research offers a comprehensive analysis of the industry.
Read more